Dr. Sandy Reyna, Head-Therapeutic Area at Novartis Gene Therapies and Kathryn McBride, parent of child with SMA: The Importance of early dia
4 de ago. de 2021 ·
10m 40s
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
A year and a half ago, a family received a devastating diagnosis in the midst of the onset of the COVID-19 pandemic. Today, that mother is sharing her son’s experience...
mostra más
A year and a half ago, a family received a devastating diagnosis in the midst of the onset of the COVID-19 pandemic. Today, that mother is sharing her son’s experience with (SMA), a rare, devastating genetic disease that is also a leading genetic cause of infant death, and how early diagnosis and treatment transformed his life. My guests are Dr. Sandy Reyna, Vice President of Global Medical Affairs, Head-Therapeutic Area at Novartis Gene Therapies and Kathryn McBride, parent of child with SMA. We talk about the signs of SMA, the importance of newborn screening and an early diagnosis, and new treatment options.
mostra menos
Información
| Autor | BizTalkPodcasts |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
